Literature DB >> 12428351

[BIS monitoring is useful for reliable intraoperative cortical mapping during brain tumor operations].

Fumio Yamaguchi1, Yoshiyuki Oi, Wataru Aoki, Rie Nakamura, Aki Igarashi, Minoru Kubota, Keiko Sawada, Toshiro Shimura, Hiroshi Takahashi, Shiro Kobayashi, Akira Teramoto.   

Abstract

Poor detection of muscle motor evoked potential (m-MEP) by electrical cortical stimulation has often been encountered during neurosurgical operations, although widely known optimal factors for reliable detection have been put into practice. We hypothesized that the depth of anesthesia influenced the detection of m-MEP. Bispectral Index (BIS) monitoring was used to assess the depth of anesthesia for 16 patients during brain tumor operations. The doses of intravenous anesthetics, propofol, were titrated according to BIS indices during operations. When BIS indices were 40 or below, detection was difficult and higher intensities of electrical stimulation were necessary to evoke m-MEPs. Furthermore, risk of seizure was relatively high due to stronger electrical stimulation. Our results suggested that a BIS index above 50 and below 70 was optimal range. BIS monitoring is a useful method for setting the optimal dose of anesthetics for reliable intraoperative cortical mapping.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428351

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  2 in total

1.  Risk of seizures during intraoperative electrocortical stimulation of brain motor areas: a retrospective study on 50 patients.

Authors:  Roberto Cordella; Francesco Acerbi; Carlo Efisio Marras; Carla Carozzi; Davide Vailati; Marco Saini; Giovanni Tringali; Paolo Ferroli; Francesco Dimeco; Angelo Franzini; Giovanni Broggi
Journal:  Neurol Sci       Date:  2012-02-17       Impact factor: 3.307

2.  Navigation-assisted subcortical mapping: intraoperative motor tract detection by bipolar needle electrode in combination with neuronavigation system.

Authors:  Fumio Yamaguchi; Hiroshi Takahashi; Akira Teramoto
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.